OAK BROOK, Ill., July 12 /PRNewswire/ -- The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year single-source agreement to Ascent, a leader in health care resource sustainability. The agreement, which has 2 optional 1-year renewal periods, became effective on July 1, 2010. Under the contract, Ascent will offer single-use device (SUD) reprocessing programs to UHC's 107 academic medical centers and 233 affiliated hospitals.
Hospitals have found that many devices labeled for single use can safely be reprocessed and reused. Because hospitals are currently scrutinizing waste, aggressively cutting costs, and trying to protect the environment, SUD reprocessing services are gaining more visibility.
UHC's award to Ascent underscores the value that Ascent brings to UHC members. In 2009 alone, Ascent's reprocessing services saved UHC affiliates a total of $12.7 million in supply costs and diverted a total of 88 tons of medical waste from landfills. The agreement also signifies the importance of a solid partnership in achieving even stronger financial results in the future.
"We awarded this contract to Ascent because of their continued demonstration of value to our members," said Jake Groenewold, UHC's senior vice president, Supply Chain. "SUD reprocessing represents a supply chain strategy that not only supports financial performance, but also addresses the increasing concerns for sustainability in health care by reducing medical waste."
"Single-source agreements are atypical in the health care industry. To receive a contract like this from UHC reaffirms the value Ascent's reprocessing programs provide to the industry," said
SOURCE University HealthSystem Consortium
Copyright©2010 PR Newswire.
All rights reserved
Related medicine technology :
1. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
2. Boston University Biomedical Engineers Find Chink in Bacterias Armor
3. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
4. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
5. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
8. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
9. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
10. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies